Reapplix

About:

Reapplix identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds.

Website: http://www.reapplix.com

Top Investors: Accelerace, Novo Holdings, Lauxera Capital Partners, Vaekstfonden, PSV

Description:

Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark.